CDKN3 anticorps
Aperçu rapide pour CDKN3 anticorps (ABIN2718434)
Antigène
Voir toutes CDKN3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Attributs du produit
- Homo sapiens cyclin-dependent kinase inhibitor 3 (CDKN3), transcript variant 1
-
Purification
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogène
- Full length human recombinant protein of human CDKN3(NP_005183) produced in HEK293T cell.
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- WB 1:2000, FLOW 1:100,
-
Commentaires
-
The concentration of the product may vary between diferrent lots.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5-1.0 mg/mL
-
Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
-
- CDKN3 (Cyclin-Dependent Kinase Inhibitor 3 (CDKN3))
-
Autre désignation
- CDKN3
-
Sujet
- The protein encoded by this gene belongs to the dual specificity protein phosphatase family. It was identified as a cyclin-dependent kinase inhibitor, and has been shown to interact with, and dephosphorylate CDK2 kinase, thus prevent the activation of CDK2 kinase. This gene was reported to be deleted, mutated, or overexpressed in several kinds of cancers. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
-
Poids moléculaire
- 23.6 kDa
-
ID gène
- 1033
-
NCBI Accession
- NM_005192
-
HGNC
- 1033
Antigène
-